Sacituzumab govitecan

Product Specifications

CAS Number

1491917-83-9

Target

Antibody-Drug Conjugates (ADCs) |||TROP2

Related Pathways

Immunology/Inflammation|||Antibody-drug Conjugate/ADC Related

Purity

0.984

Bioactivity

Sacituzumab govitecan (IMMU-132) is a humanized ADC compound targeting Trop-2 with anticancer activity for the study of refractory, locally advanced or metastatic breast cancer and uroepithelial cancer.

Shipping Conditions

Cool pack

Storage Temperature

-20°C

Available Sizes

Curated Selection

Explore Other Products

Discover premium biology products from our extensive collection of 20M+ items

TA503238BM 100 µL

CXorf26 (PBDC1) Mouse Monoclonal Antibody (HRP conjugated) [Clone ID: OTI1F3]

Ask

View Details

AM1207 2 OD, 4 OD, 50 OD

MIRacle™ hsa-miR-6885-5p miRNA Agomir/Antagomir

Ask

View Details

MBS827718-01 15 nmol

DGAT2L6 siRNA (Mouse)

Ask

View Details

MBS827718-02 30 nmol

DGAT2L6 siRNA (Mouse)

Ask

View Details

MBS827718-03 5x 30 nmol

DGAT2L6 siRNA (Mouse)

Ask

View Details

abx554674 96 Tests

Human Zinc Finger Protein 440 (ZNF440) ELISA Kit

Ask

View Details